CTEC vs. AMS, TSTL, BVC, SPEC, AKR, CNSL, ODX, SN, IDHC, and HIK
Should you be buying ConvaTec Group stock or one of its competitors? The main competitors of ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), Smith & Nephew (SN), Integrated Diagnostics (IDHC), and Hikma Pharmaceuticals (HIK). These companies are all part of the "medical" sector.
ConvaTec Group vs. Its Competitors
ConvaTec Group (LON:CTEC) and Advanced Medical Solutions Group (LON:AMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.
ConvaTec Group presently has a consensus target price of GBX 303, suggesting a potential upside of 30.60%. Advanced Medical Solutions Group has a consensus target price of GBX 287.50, suggesting a potential upside of 42.68%. Given Advanced Medical Solutions Group's higher probable upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than ConvaTec Group.
ConvaTec Group has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
Advanced Medical Solutions Group has a net margin of 8.49% compared to ConvaTec Group's net margin of 6.96%. ConvaTec Group's return on equity of 9.15% beat Advanced Medical Solutions Group's return on equity.
ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, ConvaTec Group had 11 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 11 mentions for ConvaTec Group and 0 mentions for Advanced Medical Solutions Group. ConvaTec Group's average media sentiment score of 0.14 beat Advanced Medical Solutions Group's score of 0.00 indicating that ConvaTec Group is being referred to more favorably in the media.
ConvaTec Group pays an annual dividend of GBX 5 per share and has a dividend yield of 2.2%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. ConvaTec Group pays out 84.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend.
69.1% of ConvaTec Group shares are held by institutional investors. Comparatively, 58.2% of Advanced Medical Solutions Group shares are held by institutional investors. 19.7% of ConvaTec Group shares are held by insiders. Comparatively, 3.1% of Advanced Medical Solutions Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
ConvaTec Group beats Advanced Medical Solutions Group on 12 of the 17 factors compared between the two stocks.
Get ConvaTec Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ConvaTec Group Competitors List
Related Companies and Tools
This page (LON:CTEC) was last updated on 8/5/2025 by MarketBeat.com Staff